SHARE CAPITAL (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Mar. 31, 2018
Mar. 31, 2018
Mar. 31, 2017
Opening Balance $ 20,463,014 $ 24,150,650 $ 23,491,008 $ 24,150,650 $ 5,399,851
Shares issued on acquisition (Note 4)         23,177,000
Shares issued to exchangeable shares 2,470,622   9,180,785 9,180,785  
Options exercised (Note 11)         18,166
Warrants exercised   1,125,038   1,125,038 40,195
Cashless exercise of warrants (iv)         0
Closing Balance $ 23,941,884 $ 23,491,008 $ 20,463,014 $ 20,463,014 $ 24,150,650
Exchangable Shares [Member]          
Opening Balance (in shares) 44,271,880 47,909,336   47,909,336  
Opening Balance $ 44,273 $ 47,910   $ 47,910  
Converted into common shares (in shares) (3,000,000) [1]     (3,637,456)  
Converted into common shares $ (3,000) [1]     $ (3,637)  
Closing Balance (in shares) 41,271,880   44,271,880 44,271,880 47,909,336
Closing Balance $ 41,273   $ 44,273 $ 44,273 $ 47,910
Common Shares [Member]          
Opening Balance (in shares) 205,328,106 48,885,107   48,885,107 22,591,292
Opening Balance $ 205,326 $ 48,884   $ 48,884 $ 22,591
Shares issued on acquisition (Note 4) (in shares)       0 23,650,000
Shares issued on acquisition (Note 4)       $ 0 $ 23,650
Shares issued to exchangeable shares (in shares) 3,000,000     3,637,456 2,090,664 [2]
Shares issued to exchangeable shares $ 3,000     $ 3,637 $ 2,090 [2]
Shares issued for services (in shares) [3]       0 217,047
Shares issued for services [3]       $ 0 $ 217
Shares issued on conversion of loans (in shares) 39,545,776 [4]     147,805,371 [4] 0 [5]
Shares issued on conversion of loans $ 39,546 [4]     $ 147,805 [4] $ 0 [5]
Options exercised (Note 11) (in shares)       0 110,096
Options exercised (Note 11)       $ 0 $ 110
Warrants exercised (in shares) 0     5,000,172 174,759 [6]
Warrants exercised $ 0     $ 5,000 $ 175 [6]
Cashless exercise of warrants (iv) (in shares) [7]       0 51,249
Cashless exercise of warrants (iv) [7]       $ 0 $ 51
Closing Balance (in shares) 247,873,882   205,328,106 205,328,106 48,885,107
Closing Balance $ 247,872   $ 205,326 $ 205,326 $ 48,884
Common Shares And Exchangeable Shares [Member]          
Opening Balance (in shares) 249,599,986 47,909,336   47,909,336 50,000,000
Opening Balance $ 249,599 $ 47,910   $ 47,910 $ 50,000
Converted into common shares (in shares) [2]       (3,637,456) (2,090,664)
Converted into common shares [2]       $ (3,637) $ (2,090)
Closing Balance (in shares) 289,145,762   249,599,986 249,599,986 47,909,336
Closing Balance $ 289,145   $ 249,599 $ 249,599 $ 47,910
[1] During the three month period ended June 30, 2018, 3,000,000 exchangeable shares were exchanged on a 1 for 1 basis in accordance with their terms. (March 31, 2018 – 3,637,456).
[2] During the year ended March 31, 2018, 3,637,456 exchangeable shares were exchanged for common shares on a 1 for 1 basis in accordance with their terms. (March 31, 2017 – 2,090,664 shares)
[3] The Company issued 217,047 common shares during the year ended March 31, 2017 for consulting services and recognized $59,500 of share compensation expense.
[4] During the three month period ended June 30, 2018, 39,545,776 shares of common stock were issued once the Company increased its authorized shares of common stock from 250,000,000 to 500,000,000. These shares relate to convertible loans and interest that converted on March 31, 2018 and were recorded as a liability on March 31, 2018 until the shares were issued on June 12, 2018. The liability was reclassified at June 12, 2018 into equity by recording the original value of $2,470,622 of the shares to be issued, as well as the fair value of options and warrants at June 12, 2018 net of fair value of options issued in the period ended June 12, 2018 of $1,173,534, which was charged to equity and a $2,048,697 gain on the fair value reevaluation was recognized as other income in the Statement of Operations and Comprehensive Loss.
[5] During the year ended March 31, 2018, the Company converted $9,171,604 of notes payable and interest into 147,805,371 common shares. Under the terms of this conversion the remaining $1,220,629 of principal and interest was required to be converted into 39,545,776 common shares, but were unable to be issued as a result of the Company not having enough authorized shares. The $2,470,622 value of these shares at March 31, 2018 has been classified as a liability until the common shares can be issued. In addition, there was a $376,674 loss recorded in the year connected to the difference of the $2,847,296 market value of the shares at March 31, 2018 and the value of these shares which resulted on the conversion of notes payable, the exercise price of which was based on a 30 day VWAP.
[6] During the year ended March 31, 2018, the Company consummated an offer to amend and exercise to its warrant holders, enabling them to exercise their outstanding warrants for $0.25 per share, and as a result, 5,000,172 common shares were issued for net proceeds of $1,125,038 (Note 12).
[7] During the year ended March 31, 2017, 51,249 common shares were issued as a result of a cashless exercise of 262,045 warrants with an exercise price of $0.80. Under the terms of the warrant agreement the value of the warrants on exercise is attributed to the shares on exercise and the Company has recognized a value of $43,562.